Indications and uses
■ Temporarily relieves symptoms of hay fever and other upper respiratory allergies, including: ■ runny nose ■ sneezing ■ itchy or watery eyes ■ itchy nose or throat ■ sinus pain ■ headache
■ Temporarily relieves symptoms of hay fever and other upper respiratory allergies, including: ■ runny nose ■ sneezing ■ itchy or watery eyes ■ itchy nose or throat ■ sinus pain ■ headache
■ Use as directed. Adults and children 12 years and over At onset of symptoms, dissolve 1-2 tablets under tongue every 4 hours until relieved
Relieves Runny Nose, Sneezing, Itchy or Watery Eyes, Nose or Throat
| Active Ingredients | Purpose |
| Allium Cepa 6X HPUS | hay fever, watery eyes |
| Galphimia Glauca 12X HPUS | sneezing, runny nose |
| Histaminum Hydrochloricum 12X HPUS | sinus pain |
| Luffa Operculata 12X HPUS | sinus pain, headache |
| Natrum Muriaticum 6X HPUS | sneezing, itchy eyes |
| Nux Vomica 6X HPUS (0.0000016% Alkaloids, calculated) | itchy nose & throat |
"HPUS" indicates the active ingredients are offiacial Homeopathic Pharmacopœia of the United States.
■ Temporarily relieves symptoms of hay fever and other upper respiratory allergies, including:
■ runny nose ■ sneezing ■ itchy or watery eyes
■ itchy nose or throat ■ sinus pain ■ headache
to treat food allergies.
symptoms persist for more than 7 days or worsen.
ask a health professional before use.
■ Use as directed.
| Adults and children
12 years and over | At onset of symptoms, dissolve 1-2 tablets
under tongue every 4 hours until relieved |
Acacia Gum, Lactose.
www.hylands.com or care@hylands.com
Uses Changed to ■ Temporarily relieves symptoms of hay fever and other upper respiratory allergies, including: ■ runny nose ■ sneezing ■ itchy or watery eyes ■ itchy nose or throat ■ sinus pain ■ headache
Directions Adults and children 12 years and over: Dissolve 1-2 tablets
under tongue every 4 hours until relieved.
05/09/2022 - Updates
Directions
■ Use as directed.
| Adults and children
12 years and over | At onset of symptoms, dissolve 1-2 tablets
under tongue every 4 hours until relieved. |
Hyland's
NATURALS™
SEASONAL
ALLERGY
RELIEF*
• Runny Nose
• Sneezing
• Itchy & Watery
Eyes, Nose
or Throat
60
QUICK-DISSOLVING TABLETS
HOMEOPATHIC
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54973-3012-1 | Seasonal Allergy Relief | 1 in 1 CARTON | TABLET, SOLUBLE | 1 | 9 | |
| 54973-3012-1 | Seasonal Allergy Relief | 60 in 1 BOTTLE, PLASTIC | TABLET, SOLUBLE | 60 | 9 | |
| 54973-3012-2 | Seasonal Allergy Relief | 1 in 1 CARTON | TABLET, SOLUBLE | 1 | 9 | |
| 54973-3012-2 | Seasonal Allergy Relief | 60 in 1 BOTTLE, PLASTIC | TABLET, SOLUBLE | 60 | 9 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54973-3012 | SEASONAL ALLERGY RELIEF (ONION, SODIUM CHLORIDE, HISTAMINE DIHYDROCHLORIDE, CUCUMBER, GALPHIMIA GLAUCA FLOWERING TOP, AND STRYCHNOS NUX-VOMICA SEED) TABLET, SOLUBLE [HYLAND'S INC.] | 9 | Current NDC, Legacy NDC, 4 package rows | 20250502_101e6b80-cdae-49e5-acfb-f056448856ec.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CUCUMBER | ACTIVE INGREDIENT | YY7C30VXJT | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE INGREDIENT | 93PH5Q8M7E | 1 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| CUCUMBER | ACTIVE MOIETY | YY7C30VXJT | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE MOIETY | 93PH5Q8M7E | 1 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 1 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54973-3012 | 54973-3012-1, 54973-3012-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACACIA | 5C5403N26O | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| ONION | 492225Q21H | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| HISTAMINE DIHYDROCHLORIDE | 3POA0Q644U | ACTIB |
| CUCUMBER | YY7C30VXJT | ACTIB |
| GALPHIMIA GLAUCA FLOWERING TOP | 93PH5Q8M7E | ACTIB |
| STRYCHNOS NUX-VOMICA SEED | 269XH13919 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Seasonal Allergy Relief | ONION, SODIUM CHLORIDE, HISTAMINE DIHYDROCHLORIDE, CUCUMBER, GALPHIMIA GLAUCA FLOWERING TOP, AND STRYCHNOS NUX-VOMICA SEED | Hyland's Inc. | 101e6b80-cdae-49e5-acfb-f056448856ec | 2025-04-30 | Warnings | 54973-3012-1 54973-3012-2 54973-3012 54973301202 54973301201 340a9e19-c1ce-1fa8-e063-6394a90aebf6 101e6b80-cdae-49e5-acfb-f056448856ec |
Adverse event summaries are temporarily unavailable. Other product information remains available.